XWELL, Inc. (XWEL) Financial Ratio Screen

NASDAQ Healthcare United States USD 7M
RATIOS FAIL*
Automated financial screen · activity assessed separately
XWELL, Inc. (XWEL) is potentially non-compliant in the automated ratio model. The company's debt ratio of 42.5% exceeds the 30% MSCI new-inclusion threshold relative to total assets. XWELL, Inc. operates in the Healthcare sector.

Track XWEL screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

XWEL financial screening at a glance

RATIOS FAIL*Financial ratios shown separately from business review — not a fatwa
Debt ratio
42.5%
Fail vs 30%
Cash ratio
46.5%
Fail vs 30%
Receivables + cash
53.6%
Fail vs 30%
Impermissible income
1.1%
Pass vs 5%

Calculation date: 2026-08-31. Financial period used: December 2024. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria not metAt least one available ratio exceeds its threshold
FTSE/Yasaar-styleFinancial criteria not metAt least one available ratio exceeds its threshold
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2024Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Diagnostics & Research) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 42.5%
/ 30%
46.5%
/ 30%
53.6%
/ 30%
1.12%
/ 5%
RATIOS FAIL*
FTSE 42.5%
/ 33%
46.5%
/ 33%
53.6%
/ 50%
1.12%
/ 5%
RATIOS FAIL*

Financial Highlights

EPS
$-3.34
P/B Ratio
-1.1
EV/EBITDA
-2.4
EV: $22M
Revenue
$34M
Growth: -12.8%
Beta
0.9
Average volatility
Current Ratio
1.1

Profitability

Gross Margin 19.3%
Operating Margin -3.8%
Net Margin -51.8%
Return on Equity (ROE) -159.0%
Return on Assets (ROA) -22.5%

Cash Flow & Balance Sheet

Operating Cash Flow-$11M
Free Cash Flow-$13M
Total Debt$11M
Debt-to-Equity281.4
Current Ratio1.1
Total Assets$25M

Price & Trading

Last Close$1.29
50-Day MA$0.83
200-Day MA$0.91
Avg Volume9.1M
Beta0.9
52-Week Range
$0.26
$2.20

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2024. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About XWELL, Inc. (XWEL)

CEO
Mr. Ezra T. Ernst
Employees
246
Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Exchange
NASDAQ
Market Cap (listing currency)
USD 7M
Currency
USD

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is XWELL, Inc. (XWEL) halal to invest in?

The current automated result is Financial criteria not met or an activity exclusion was detected. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is XWELL, Inc.'s debt ratio?

XWELL, Inc.'s debt ratio is 42.5% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are XWELL, Inc.'s key financial metrics?

XWELL, Inc. has a market capitalization of USD 7M in its listing currency, and revenue of $34M. The company maintains a gross margin of 19.3% and a net margin of -51.8%. Return on equity stands at -159.0%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2024. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.